Chronopharmacology of Gemcitabine in the Treatment of Non-small Cell Lung Cancer / 中国药房
China Pharmacy
;
(12)1991.
Article
in Chinese
| WPRIM
| ID: wpr-533329
ABSTRACT
0.05) but the incidence of toxicities in Group B was higher than in the other two groups. CONCLUSION:
Comparatively speaking,Gemcitabine administered at 8 ∶ 00 was proved to be safer and more effective as compared with the other two groups in the treatment of NSCLC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacy
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS